Profilo
Alan Naylor founded Pathios Therapeutics Ltd. in 2017, where he is working as Head-Drug Discovery from 2017.
Dr. Naylor also currently works at Brandon Capital Partners Pty Ltd., as Advisor from 2015.
Dr. Naylor received his graduate degree from the University of Liverpool Management School.
Posizioni attive di Alan Naylor
| Società | Posizione | Inizio |
|---|---|---|
Pathios Therapeutics Ltd.
Pathios Therapeutics Ltd. BiotechnologyHealth Technology Engages in discovering and developing novel small molecule drugs | Fondatore | 01/01/2017 |
Brandon Capital Partners Pty Ltd.
Brandon Capital Partners Pty Ltd. Investment ManagersFinance Brandon Capital Partners invests in companies located in the Australia and New Zealand. The firm focuses on a broad range of sectors and industries. It provides financing for early stage capital requirements. | Consulente / Consigliere | 01/01/2015 |
Formazione di Alan Naylor
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
Brandon Capital Partners Pty Ltd.
Brandon Capital Partners Pty Ltd. Investment ManagersFinance Brandon Capital Partners invests in companies located in the Australia and New Zealand. The firm focuses on a broad range of sectors and industries. It provides financing for early stage capital requirements. | Finance |
Pathios Therapeutics Ltd.
Pathios Therapeutics Ltd. BiotechnologyHealth Technology Engages in discovering and developing novel small molecule drugs | Health Technology |
University of Liverpool Management School
University of Liverpool Management School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















